Always up to date.

Our goal is to develop procedure and anatomy specific devices that lead in collaboration with our customers to predictable and superior treatment outcomes. Read on to learn more about our solutions, priorities, partnerships and how we create sustainable value with our teams.

Press release 2024 annual general meeting

The shareholders of Medartis Holding AG (SIX: MED) today approved all the substantive proposals of the Board of Directors with a clear majority of more than 94.8%. All members of the Board of...

Read more

Medartis successfully places CHF 115.8 million convertible bonds due 2031

Medartis Holding AG (SIX: MED, the “Company” or “Medartis”), a specialized orthopaedic company for head and extremity surgery, announces the successful placement of senior unsecured guaranteed...

Read more

Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16%

Demonstrating further market share gains, full-year 2023 sales rose by 20.5%(CER) to CHF 212.0 million. The EMEA region was the driving force with strong growth of 19.8%, exceeding the CHF 100 million...

Read more